XML 19 R4.htm IDEA: XBRL DOCUMENT v3.23.1
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENTS OF INCOME      
Sales, net (notes 1, 3, 9 and 11) $ 52,281 $ 49,054 $ 42,178
Cost of goods sold 20,085 18,137 16,630
Gross profit 32,196 30,917 25,548
Sales and marketing 1,507 1,414 1,554
Research and development 493 526 486
General and administrative 10,406 10,097 9,800
Operating income 19,790 18,880 13,708
Dividend and interest income 661 166 112
Royalty income (note 12) 20 15 20
Other, net 188 0 0
Income before provision for income taxes 20,659 19,061 13,840
Provision for income taxes (note 7) 4,186 4,273 3,042
Net income $ 16,473 $ 14,788 $ 10,798
Earnings per common share (basic) (note 1) $ 4.53 $ 4.05 $ 2.95
Earnings per common share (diluted) (note 1) $ 4.52 $ 4.04 $ 2.94
Other comprehensive income (loss)      
Foreign currency translation net of taxes of $0 in all periods $ (2,986) $ (773) $ 1,502
Total comprehensive income $ 13,487 $ 14,015 $ 12,300